FDA issues three guidances to expand cancer clinical trial eligibility

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsPharmaceuticalsRegulatory Intelligence/PolicyUnited States